Objective-To assess oesophageal Doppler ultrasonography as a convenient means of optimising positive end expiratory pressure for maximal delivery of oxygen to tissues.
Interventions-Incremental increases in positive end expiratory pressure followed when indicated by stepwise decreases.
End point-The positive end expiratory pressure providing maximal delivery of oxygen to tissues.
Measurements and main results-Arterial oxygen saturation increased with positive end expiratory pressure in all patients by an average of 6-1%. In nine ofthe 11 studies, however, cardiac output fell by 15% to 30% after the second increment. On the two other occasions cardiac output and oxygen delivery rose by up to 54%. Positive end expiratory pressure was decreased on seven occasions; there was considerable individual variation in the time taken for cardiac output to rise and arterial oxygen saturation to fall. In six patients good agreement was seen between the results from Doppler ultrasonography and thermodilution, the mean of the differences being -0-3% with narrow limits of agreement (-14-4% to 13-9%).
Conclusions Physical manoeuvres such as endotracheal suction and turning the patient were not performed and ventilator settings, drug doses, and the administration of boluses of fluid were not changed for at least one hour before the start of the study. Similarly, no alterations were made during the course of the investigation other than changing the positive end expiratory pressure. The study was discontinued if another manoeuvre had to be performed that might have disturbed the steady state-for example, suction.
A 5 1 MHz continuous wave oesophageal Doppler transducer connected to a spectral analyser system (Doptek, Chichester, Sussex) was used. The transducer was inserted through the mouth to a depth of about 30-40 cm until blood flow was detected. It was focused on the midstream flow of the descending thoracic aorta by rotating the probe until velocity waveforms with minimal spectral dispersion were seen that were characteristic of midstream blood flow in the aorta."' The area of each waveform-the velocity-time integral or stroke distance-is a linear measure of the left ventricular stroke volume that passes through the descending thoracic aorta. The stroke distance and heart rate were computed semiautomatically by using a 
An index of oxygen delivery was calculated from the formula >(haemoglobin concentrationx1 34xarterial oxygen saturation) x (stroke distance x heart rate).
The percentage change in cardiac output from baseline values measured by Doppler ultrasonography and thermodilution was compared according to the method described by Bland and Altman. II The study was approved by the hospital district medical ethics committee.
Results
Ten patients were studied on a total of eleven occasions, and their details are shown in table I.
Arterial oxygen saturation increased in all patients after increases in positive end expiratory pressure. The mean baseline saturation of 90 7% (SD 8 5%) rose to 96-2% (6-1%) at the highest value, an average increase of 6 1%. In all but two patients, however, the increase in positive end expiratory pressure resulted in reductions in cardiac output that exceeded 15% by the second increment (range -15% to -30%). Corresponding decreases of -2% to -25% were seen in the delivery of oxygen to the tissues (table II) .
Increases in cardiac output and delivery of oxygen to the tissues of 40 4% and 53-5% respectively occurred in one patient with left ventricular failure (case 2) when positive end expiratory pressure was increased from 6 to 18 cm H20. The procedure was repeated five days later when the heart failure was controlled; on this occasion a fall in cardiac output of 19-3% was seen on increasing the pressure from 6 to 12 cm H20. One patient (case 9) became increasingly hypotensive and oliguric after positive end expiratory pressure was increased from 0 to 10 cm H20 and recovered after having been given a colloid bolus of 700 ml. Oesophageal Doppler ultrasonography thus provides a useful alternative means of determining the optimal positive end expiratory pressure for the maximal delivery of oxygen to body tissues. The transducer is easily inserted and excellent signals are uniformly obtained within one to two minutes. Because of the stability of the transducer the error in recording data is negligible; the transducer may either be left in situ for days without complication or be reinserted as necessary. The good agreement shown with thermodilution in our patients suggests that there are no large changes in the ratio of descending aortic flow to total cardiac output. This implies that positive end expiratory pressure does not appreciably redistribute regional cardiac output.
Measurements after decreases in positive end
Apart from optimising the delivery of oxygen to the tissues oesophageal Doppler ultrasonography could be used to ensure that attempts to improve arterial blood oxygenation, reduce venoarterial admixtures, or lower inspired oxygen concentrations to non-toxic values by increasing positive end expiratory pressure do not have too deleterious an effect on the oxygen delivery. Furthermore, the efficacy of therapeutic manoeuvres such as fluid administration38 6 given to restore the delivery of oxygen to tissues may be assessed.
In conclusion, oesophageal Doppler ultrasonography offers a reliable, safe, rapid, continuous, and comparatively non-invasive means of finding the optimal positive end expiratory pressure for the maximal delivery of oxygen to tissues in critically ill patients. It can be easily performed at regular intervals as any important change in haemodynamic state, either spontaneous or therapeutic, may alter the optimal positive end expiratory pressure. Increasing positive end expiratory pressure to improve the oxygenation of blood may result in major haemodynamic disadvantages, even at low values. Our results highlight the need to monitor circulatory changes occurring in consequence. Design-Randomised double blind controlled trial of oral rehydration solution containing L-alanine and glucose.
Setting-Inpatient service of a hospital treating diarrhoea.
Patients-97 Male patients aged 6-59 years admitted to the hospital with acute and severe dehydration due to diarrhoea associated with Vibrio cholerae or enterotoxigenic Escherichia coli. Forty nine received the standard glucose based oral rehydration solution (control group) and 48 this solution with alanine added (study group).
Interventions-All of the patients received rapid intravenous acetate solution for the initial four hours after admission, which fully corrected the signs of dehydration. They were then admitted to the study and randomised. Immediately after the intravenous treatment oral rehydration treatment was started. All of the patients received oral tetracycline for 48 hours, starting 24 hours after start of the study. If signs of dehydration reappeared during oral treatment patients were given rapid intravenous acetate solution until they were fully corrected and then continued to take the assigned oral rehydration solution.
End point-Passage of the last watery stool. Measurements and main results-The median stool output/kg body weight during the initial 24 hours of oral rehydration treatment and until diarrhoea stopped was reduced in the study group compared with the control group from 309 ml to 196 ml and from 393 ml to 236 ml respectively. Intake of oral rehydration solution and intravenous acetate solution was reduced from 455 ml to 308 ml and from 616 ml to 425 ml respectively. Two patients in the study group compared with 18 patients in the control group required unscheduled rapid intravenous acetate solution to correct signs of dehydration during oral rehydration treatment.
Conclusion-Oral rehydration solution contatlning L-alanine was considerably better than standard oral rehydration solution at reducing the severity of symptoms and the need for fluid of male patients with diarrhoea associated with V cholerae and entefotoxigenic E coli.
Introduction
Treatment with glucose based oral rehydration solution is effective for preventing and treating diarrhoea.'-' It does not, however, reduce the volume or frequency of stools or the duration of diarrhoea. There are two types of alternative formulation. One type contains glucose or a glucose polymer and an amino acid or a peptide, or both, in varying concentrations6: this approach was stimulated by studies in children7 and adults' that used formulations containing glucose and glycine. In the other type of formulation glucose is replaced by a staple food (cereals, legumes, or roots) as a source of starch and protein: this approach was based on studies that showed that a rehydration solution containing 50 or 80 g of rice powder per litre in place of glucose can reduce stool volume substantially.9"' Alanine has been proposed as a component of an improved oral rehydration solution formulation.1' Studies have shown that it enhances the absorption of sodium and water from the small intestine, the amount of absorption increasing with its concentration.'2 Alanine is a white, odourless, crystalline powder with a sweetish taste and is soluble in water; it is present in many foodstuffs and has been used as a dietary supplement." Alanine 50 g each day orally in divided doses reversed hypoglycaemia and ketosis and reduced catabolism of muscle in obese subjects starved for two weeks. A study of piglets with transmissible gastroenteritis showed that alanine with glucose caused a significantly greater absorption of sodium by the jejunal mucosa than either alanine or glucose alone.` ' We report the results of a double blind randomised trial of an oral rehydration solution containing glucose and alanine.
Patients and methods
Male patients aged 6-59 years with a history of watery diarrhoea of24 hours or less and clinical signs of severe dehydration were included in the study. Criteria for exclusion were: a history of treatment with anti-
